Czechia· CZ-0165687
CISATRACURIUM KABI
A cisatracurium product containing cisatracurium besilate, registered in Czechia by Fresenius Kabi s.r.o., Praha. The same ATC class is registered in 15 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Cisatracurium is registered in 15 of 19 countries.
Countries holding a registration under ATC M03AC11 (cisatracurium), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 8 of them publish a price we can compare per daily dose
Cisatracurium · ATC M03AC11
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- CISATRACURIUM BESILATE
- Manufacturer
- Fresenius Kabi s.r.o., Praha
- Country
- Czechia (CZ)
- ATC code
- M03AC11
- ATC class
- Cisatracurium
- Defined daily dose
- 10.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
89 interactions on record for cisatracurium.
Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cisatracurium · interactions on record
89 records
- 12 severe
- 44 moderate
- 4 minor
- 29 info
Most severe, free to view
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- ParomomycinA07AA06severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cisatracurium in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumCisatracurium Accord Healthcare 2 mg/mlAccord Healthcare
- SpainCISATRACURIO ACCORDPHARMA 2 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION EFGAccord Healthcare S.L.U.
- United StatesCisatracuriumFresenius Kabi USA, LLC
- FinlandCisatracurium AccordAccord Healthcare B.V.
- PolandCisatracurium AccordAccord Healthcare Polska Sp. z o.o.
- NorwayCisatracurium kalceksAS Kalceks
- IrelandCisatracurium 2 mg/ml solution for injection/infusionNoridem Enterprises Limited
- SwedenCisatracurium Noridem 2 mg/ml Injektions-/infusionsvätska, lösningNoridem Enterprises Ltd
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Cisatracurium Accordpharma, Cisatracurium Hikma
- Belgium · Cisatracurium Fresenius Kabi, Cisatracurium Hikma
- Cyprus · Cisatracurium Accordpharma, Cisatral
- Germany · Cisatracurium Hameln, Cisatracurium Hikma
- Denmark · Cisatracurium Accordpharma, Cisatracurium Fresenius Kabi
- Estonia · Cisatracurium Kalceks
- Spain · Cisatracurio Accordpharma, Cisatracurio Hikma
- Finland · Cisatracurium Accordpharma, Cisatracurium Fresenius Kabi
- France · Cisatracurium Accord, Cisatracurium Accordpharma
- United Kingdom (Northern Ireland) · Cisatracurium, Cisatracurium Accord Healthcare
- Greece · Cisatral
- Croatia · Cisatrakurij Accordpharma
- Hungary · Cisatracurium Accordpharma, Cisatracurium Kabi
- Ireland · Cisatracurium Kalceks, Cisatracurium Noridem Enterprises
- Italy · Cisatracurio Hikma, Cisatracurio Kalceks
- Lithuania · Cisatracurium Kalceks
- Luxembourg · Nimbex
- Latvia · Cisatracurium Kalceks
- Netherlands · Cisatracurium Accord, Cisatracurium Accordpharma
- Norway · Cisatracurium Accordpharma, Cisatracurium Kalceks
- Poland · Cisatracurium Accordpharma, Cisatracurium Kabi
- Portugal · Cisatracúrio Accord, Cisatracúrio Accordpharma
- Romania · Cisatracurium Noridem
- Sweden · Cisatracurium Noridem
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/93354c26-803b-4bd2-85d0-ff8472c0a28a GET /v1/drugs/93354c26-803b-4bd2-85d0-ff8472c0a28a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INJ/INF SOL",
"source": "sukl",
"strength": "2MG/ML",
"pack_size": "10X5ML",
"substance": "CISATRACURIUM BESILATE",
"cz_kod_sukl": "0165687",
"product_type": "CH",
"substance_codes": "14387",
"registration_state": "R",
"registration_number": "63/568/11-C"
}See everything about cisatracurium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.